27/04/2026
Liver vs Evidence – Are we missing the silent disease?
In everyday clinical practice, we increasingly encounter patients influenced by social media, -generated content, and non-medical advice. While access to information has improved, it has also led to widespread misconceptions about liver disease.
📊 our recent review published in (ClinMed), where we explore a growing challenge in modern clinical practice—misconceptions surrounding liver disease.
🔹 Normal liver enzymes ≠ normal liver
🔹 MASLD is now the leading cause of chronic liver disease globally
🔹 Significant fibrosis can exist even with normal LFTs
🔹 Non-invasive tools like FIB-4 can transform early detection in primary care
🔹 Lifestyle intervention (10–15% weight loss) remains a cornerstone of management
🚨 The real challenge?
Delayed diagnosis, under-referral, and missed opportunities for early intervention.
👉 As clinicians, we need to shift from reactive care to proactive risk stratification:
Identify high-risk patients (T2DM, obesity, metabolic syndrome)
Use simple non-invasive tools
Stratify and refer appropriately
Invest time in patient education to counter myths
💡 Liver disease remains a silent epidemic—but one we can detect earlier and manage better with the right approach.
I’ve created a visual summary of the paper for quick reference 👇
https://www.sciencedirect.com/science/article/pii/S147021182500243X?via%3Dihub
---
📍Would be interested to hear how others are addressing misinformation and delayed diagnosis in their practice.
